The World Health Organization is recommending an antibody cocktail to treat non-severe cases of COVID-19.
The recommended treatment uses two antibody drugs, casirivimab and imdevimab.
The WHO included the recommendation in its updated guideline for COVID-19 therapeutics released on Friday.
The results of clinical tests show the treatment resulted in a shorter recovery time and a lower risk of progressing to severe illness and hospitalization than conventional treatment.
The WHO's previous recommendations were for severe cases of COVID-19.
Distribution to developing nations where the coronavirus is raging is a challenge as the drugs are expensive and supplies are limited.
The WHO is asking the maker of these drugs for help, including the possibility of donating them.